Fund shareholders of Pulse Biosciences Inc
ISIN US74587B1017 · United States · LEI 529900NJUBI06118FM73
- Fund shareholders
- 102
- Of which ETFs
- 18 84 other funds
- Value held
- 62.7M $
- Share of capital
- 4.3 % of 71.3M shares on Jul 31, 2026
This issuer has other securities : Pulse Biosciences Inc (US74587B1439)
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 7 | 131.1 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 5 | 108 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| MFS New Discovery Series MFS VARIABLE INSURANCE TRUST | 0.37 % | as of Mar 31, 2026 ↗ |
| Zacks Small-Cap Core Fund Zacks Trust | 0.36 % | as of Feb 28, 2026 ↗ |
| Inspire Small/Mid Cap ETF Northern Lights Fund Trust IV | 0.25 % | as of Feb 28, 2026 ↗ |
| Eventide Small Cap ETF Strategy Shares | 0.10 % | as of Apr 30, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 0.08 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.08 % | as of Mar 31, 2026 ↗ |
| AQR Small Cap Momentum Style Fund AQR Funds | 0.05 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.04 % | as of Mar 31, 2026 ↗ |
| Longboard Fund NORTHERN LIGHTS FUND TRUST II | 0.04 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust | 0.03 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 102 | +4 | 3,033,952 | +16.2 % |
| 2026Q1 | 98 | -3 | 2,610,996 | +1.0 % |
| 2025Q4 | 101 | +4 | 2,585,700 | -6.8 % |
| 2025Q3 | 97 | -1 | 2,773,686 | +5.9 % |
| 2025Q2 | 98 | +3 | 2,619,595 | -3.7 % |
| 2025Q1 | 95 | +6 | 2,719,237 | +8.8 % |
| 2024Q4 | 89 | +7 | 2,499,956 | +13.0 % |
| 2024Q3 | 82 | +1 | 2,212,630 | +7.6 % |
| 2024Q2 | 81 | -1 | 2,055,894 | +14.0 % |
| 2024Q1 | 82 | +9 | 1,803,492 | +29.8 % |
| 2023Q4 | 73 | 1,389,154 |
Institutional managers
88 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 1,339,778 | 28.9M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 866,061 | 18.7M $ | as of Mar 31, 2026 |
| Portolan Capital Management, LLC | 733,372 | 15.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 491,946 | 10.6M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 462,899 | 10M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 456,927 | 9.9M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 265,164 | 5.7M $ | as of Mar 31, 2026 |
| GRIFFIN ASSET MANAGEMENT, INC. | 225,177 | 4.9M $ | as of Mar 31, 2026 |
| LMR Partners LLP | 213,137 | 4.6M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 187,272 | 4M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 147,768 | 3.2M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 142,150 | 3.1M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 81,252 | 1.8M $ | as of Mar 31, 2026 |
| Westside Investment Management, Inc. | 70,492 | 1.5M $ | as of Mar 31, 2026 |
| Panoramic Capital, LLC | 58,054 | 1.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 55,817 | 1.2M $ | as of Mar 31, 2026 |
| Parkman Healthcare Partners LLC | 50,125 | 1.1M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 45,435 | 980.9K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 43,165 | 931.9K $ | as of Mar 31, 2026 |
| Swiss National Bank | 39,100 | 844.2K $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 38,477 | 830.7K $ | as of Mar 31, 2026 |
| UBS Group AG | 33,954 | 733.1K $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 31,820 | 687K $ | as of Mar 31, 2026 |
| FORMULA GROWTH LTD | 30,000 | 647.7K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 28,711 | 619.9K $ | as of Mar 31, 2026 |
Declared shareholders of Pulse Biosciences Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| ROBERT W. DUGGAN and 2 others | 71.90 % | 49,706,423 | as of May 11, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Fund shareholders of Pulse Biosciences Inc". https://titelia.com/en/stocks/pulse-biosciences-inc-US74587B1017